 |
PDBsum entry 4ckr
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transferase
|
 |
|
Title:
|
 |
Crystal structure of the human ddr1 kinase domain in complex with ddr1-in-1
|
|
Structure:
|
 |
Epithelial discoidin domain-containing receptor 1. Chain: a. Fragment: kinase domain, residues 601-913. Synonym: epithelial discoidin domain receptor 1, cd167 antigen-like family member a, cell adhesion kinase, discoidin receptor tyrosine kinase, hgk2, mammary carcinoma kinase 10, mck-10, protein-tyrosine kinase 3a, protein-tyrosine kinase rtk-6, trk e, tyrosine kinase ddr, tyrosine-protein kinase cak, cd167a. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Expressed in: spodoptera frugiperda. Expression_system_taxid: 7108. Expression_system_cell_line: sf9. Other_details: mammalian gene collection (mgc)
|
|
Resolution:
|
 |
|
2.20Å
|
R-factor:
|
0.201
|
R-free:
|
0.247
|
|
|
Authors:
|
 |
P.Canning,J.M.Elkins,S.Goubin,P.Mahajan,T.Krojer,J.A.Newman,S.Dixon- Clarke,A.Chaikuad,F.Von Delft,C.H.Arrowsmith,A.M.Edwards,C.Bountra, A.Bullock
|
|
Key ref:
|
 |
H.G.Kim
et al.
(2013).
Discovery of a potent and selective DDR1 receptor tyrosine kinase inhibitor.
Acs Chem Biol,
8,
2145-2150.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
07-Jan-14
|
Release date:
|
15-Jan-14
|
|
|
Supersedes:
|
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
Q08345
(DDR1_HUMAN) -
Epithelial discoidin domain-containing receptor 1 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
913 a.a.
295 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 1 residue position (black
cross)
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.7.10.1
- receptor protein-tyrosine kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
L-tyrosyl-[protein] + ATP = O-phospho-L-tyrosyl-[protein] + ADP + H+
|
 |
 |
 |
 |
 |
L-tyrosyl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-tyrosyl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Acs Chem Biol
8:2145-2150
(2013)
|
|
PubMed id:
|
|
|
|
|
| |
|
Discovery of a potent and selective DDR1 receptor tyrosine kinase inhibitor.
|
|
H.G.Kim,
L.Tan,
E.L.Weisberg,
F.Liu,
P.Canning,
H.G.Choi,
S.A.Ezell,
H.Wu,
Z.Zhao,
J.Wang,
A.Mandinova,
J.D.Griffin,
A.N.Bullock,
Q.Liu,
S.W.Lee,
N.S.Gray.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The DDR1 receptor tyrosine kinase is activated by matrix collagens and has been
implicated in numerous cellular functions such as proliferation,
differentiation, adhesion, migration, and invasion. Here we report the discovery
of a potent and selective DDR1 inhibitor, DDR1-IN-1, and present the 2.2 Å DDR1
co-crystal structure. DDR1-IN-1 binds to DDR1 in the 'DFG-out' conformation and
inhibits DDR1 autophosphorylation in cells at submicromolar concentrations with
good selectivity as assessed against a panel of 451 kinases measured using the
KinomeScan technology. We identified a mutation in the hinge region of DDR1,
G707A, that confers >20-fold resistance to the ability of DDR1-IN-1 to
inhibit DDR1 autophosphorylation and can be used to establish what pharmacology
is DDR1-dependent. A combinatorial screen of DDR1-IN-1 with a library of
annotated kinase inhibitors revealed that inhibitors of PI3K and mTOR such as
GSK2126458 potentiate the antiproliferative activity of DDR1-IN-1 in colorectal
cancer cell lines. DDR1-IN-1 provides a useful pharmacological probe for
DDR1-dependent signal transduction.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |